QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients

1. World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and preventive therapy for people living with HIV in resource-constrained settings. 2011. Geneva, Switzerland. Available at <http://apps.who.int/iris/bitstream/10665/44472/1/9789241500708_eng.pdf>. Accessed June 1, 2016.

2. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230-8.

3. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.

4. Mazurek GH, Jereb J, Vernon A, et al. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect <i>Mycobacterium tuberculosis</i> infection–United States, 2010. MMWR Recomm Rep. 2010;59:1-25.

5. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, et al. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis. 2011;15:14-23.

6. Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent <i>Mycobacterium tuberculosis</i> infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88-99.

7. Gray J, Reves R, Johnson S, et al. Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis. 2012;54:e20-3.

8. Aichelburg MC, Reiberger T, Breitenecker F, et al. Reversion and conversion of interferon-γ release assay results in HIV-1-infected individuals. J Infect Dis. 2014;209:729-33.

9. Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004;38:754-6.

10. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009;9:23.

11. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to <i>Mycobacterium tuberculosis</i>-specific antigens. Am J Respir Crit Care Med. 2007;175:282-7.

12. Chiappini E , Bonsignori F , Mangone G, et al. Serial T-SPOT.TB and QuantiFERON TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection. Pediatr Infect Dis J. 2012;31:974-7.

13. Lee SW, Lee SH, Yim JJ. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection. 2012;40:431-5.

14. Johnson JL, Geldenhuys H, Thiel BA, et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB Gold In-Tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Chest. 2014;145:612-7.

15. Pullar ND, Steinum H, Bruun JN, et al. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study. BMC Infect Dis. 2014;14:667.

16. WHO. Tuberculosis country profiles, 2014. Available at &lt;http://www.who.int/tb/country/data/profiles/en/&gt;. Accessed August 13, 2016.

17. Apisarnthanarak A, Mundy LM. Application of a 3-item adherence metric to monitor antiretroviral medication adherence in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;55:528.

18. Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:1-10.

19. Lee SW, Lee SH, Yim JJ. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection. 2012;40:431-5.

20. Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology. 2008;13:468-72.

21. Bastos ML, Menzies D, Belo MT, et al. Changes in QuantiFERON-TB Gold In-Tube results during treatment for tuberculous infection. Int J Tuberc Lung Dis. 2013;17:909-16.

22. Vilaplana C, Ruiz-Manzano J, Gil O, et al. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays. Scand J Immunol. 2008;67:610-7.